Status: Not yet recruiting
Adebrelimab Maintenance Therapy for LS-SCLC Post Induction Chemo-Adebrelimab Plus CRT or CRT Alone
Observation and Evaluation of the Efficacy and Safety of Adalimumab Combined with Chemotherapy Followed by Radiotherapy or Radiotherapy Alone as First-Line Treatment for Limited-Stage Small Cell Lung Cancer
Participants needed: 76
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Peking University Cancer Hospital & InstituteUpdated: Feb 4, 2026Locations: 1
Eligibility criteria
Age: 18-75 years old, male or female; [+9]
Mixed SCLC and extensive-stage SCLC; [+11]